Last updated: 15 days ago
AstraZeneca's Calquence Gains EU Approval: A Game-Changer for CLL Treatment
AstraZeneca's 6-K filing reveals EU approval for Calquence in CLL, showcasing superior trial results and market potential.
Posts With Tag Calquence
Showing 1 - 3 of 3 Posts
Last updated: about 2 months ago
AstraZeneca's Calquence Approved for MCL: A Game Changer in EU Oncology
AstraZeneca's Calquence receives EU approval for untreated MCL, offering new hope with improved survival rates. This report details clinical trial results and market implications.
Last updated: 3 months ago
AstraZeneca's Calquence: Pioneering BTK Inhibitor for 1st-Line MCL in EU Approval Report
Explore AstraZeneca's Calquence, the first BTK inhibitor recommended for 1st-line MCL in the EU, based on ECHO Phase III trial findings showcasing improved survival rates.